Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Jeffrey R. Strawn, Laura Geracioti, Neil Rajdev, Kelly Clemenza & Amir Levine. (2018) Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opinion on Pharmacotherapy 19:10, pages 1057-1070.
Read now
Read now
Cody J Connor. (2017) Management of the psychological comorbidities of dermatological conditions: practitioners’ guidelines. Clinical, Cosmetic and Investigational Dermatology 10, pages 117-132.
Read now
Read now
Jennifer A Reinhold & Karl Rickels. (2015) Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert Opinion on Pharmacotherapy 16:11, pages 1669-1681.
Read now
Read now
Michael Linden, Borwin Bandelow, Reinhard Joachim Boerner, Matthias Brasser, Siegfried Kasper, Hans-Jürgen Möller, Lena Pyrkosch, Hans-Peter Volz & Hans-Ulrich Wittchen. (2013) The best next drug in the course of generalized anxiety disorders: the “PN-GAD-algorithm”. International Journal of Psychiatry in Clinical Practice 17:2, pages 78-89.
Read now
Read now
H. Parmentier, J. García-Campayo & R. Prieto. (2013) Comprehensive review of generalized anxiety disorder in primary care in Europe. Current Medical Research and Opinion 29:4, pages 355-367.
Read now
Read now
Rodrigo CL Edelmuth, Michael A Nitsche, Linamara Battistella & Felipe Fregni. (2010) Why do some promising brain-stimulation devices fail the next steps of clinical development?. Expert Review of Medical Devices 7:1, pages 67-97.
Read now
Read now
SS Stamouli, A Yfantis, E Lamboussis, A Liakouras, V Lagari, M Tzanakaki, D Giailoglou, M Legault & IA Parashos. (2009) Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients. Expert Opinion on Pharmacotherapy 10:6, pages 937-945.
Read now
Read now
David M Marks, Min-Hyeon Park, Byung-Joo Ham, Changsu Han, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2008) Paroxetine: safety and tolerability issues. Expert Opinion on Drug Safety 7:6, pages 783-794.
Read now
Read now
Cyril Höschl & Jaromír Švestka. (2008) Escitalopram for the treatment of major depression and anxiety disorders. Expert Review of Neurotherapeutics 8:4, pages 537-552.
Read now
Read now
Joseph Zohar. (2008) Escitalopram in the treatment of obsessive–compulsive disorder. Expert Review of Neurotherapeutics 8:3, pages 339-349.
Read now
Read now
Borwin Bandelow, Joseph Zohar, Eric Hollander, Siegfried Kasper, Hans-Jürgen Möller, WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR ANXIETY OBSESSIVE-COMPULSIVE POST-TRAUMATIC STRESS DISORDERS, Borwin Bandelow, Joseph Zohar, Eric Hollander, Siegfried Kasper, Hans-Jürgen Möller & WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR ANXIETY OBSESSIVE-COMPULSIVE POST-TRAUMATIC STRESS DISORDERS. (2008) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision. The World Journal of Biological Psychiatry 9:4, pages 248-312.
Read now
Read now
David S Baldwin & Khalil Ajel. (2007) Role of pregabalin in the treatment of generalized anxiety disorder. Neuropsychiatric Disease and Treatment 3:2, pages 185-191.
Read now
Read now
Raymond W Lam & Lieven Annemans. (2007) Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders. Expert Review of Pharmacoeconomics & Outcomes Research 7:6, pages 559-576.
Read now
Read now
Silvio R Bareggi, Emanuela Mundo, Bernardo Dell'Osso & A Carlo Altamura. (2007) The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 741-753.
Read now
Read now
Chi-Un Pae & Ashwin A Patkar. (2007) Paroxetine: current status in psychiatry. Expert Review of Neurotherapeutics 7:2, pages 107-120.
Read now
Read now
Michael E Thase. (2006) Managing depressive and anxiety disorders with escitalopram. Expert Opinion on Pharmacotherapy 7:4, pages 429-440.
Read now
Read now
Thomas C. Baghai, Hans-Peter Volz & Hans-Jürgen Möller. (2006) Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities. The World Journal of Biological Psychiatry 7:4, pages 198-222.
Read now
Read now
Raymond W. Lam. (2006) Challenges in the treatment of anxiety disorders: beyond guidelines. International Journal of Psychiatry in Clinical Practice 10:sup3, pages 18-24.
Read now
Read now
David S. Baldwin. (2006) The importance of long-term tolerability in achieving recovery. International Journal of Psychiatry in Clinical Practice 10:sup1, pages 31-37.
Read now
Read now
Raymond W. Lam. (2006) Generalized anxiety disorder: how to treat, and for how long?. International Journal of Psychiatry in Clinical Practice 10:sup1, pages 10-15.
Read now
Read now
Siegfried Kasper. (2006) Anxiety disorders: under-diagnosed and insufficiently treated. International Journal of Psychiatry in Clinical Practice 10:sup1, pages 3-9.
Read now
Read now